Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Actinium Pharmaceuticals, Inc. Snapshot 5
Actinium Pharmaceuticals, Inc. Overview 5
Key Information 5
Key Facts 5
Actinium Pharmaceuticals, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Actinium Pharmaceuticals, Inc. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Actinium Pharmaceuticals, Inc. - Pipeline Products Glance 12
Actinium Pharmaceuticals, Inc. - Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
Actinium Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Actinium Pharmaceuticals, Inc. - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Actinium Pharmaceuticals, Inc. - Drug Profiles 16
Iomab-B 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Actimab-A 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
BC-8Y90 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
BC-8SA 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Actimab-B 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Actimab-Br 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Actimab-C 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Actimab-P 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Monoclonal Antibody Conjugate for Hematological Tumor and Oncology 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Monoclonal Antibody Conjugate for Oncology 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Actinium Pharmaceuticals, Inc. - Pipeline Analysis 28
Actinium Pharmaceuticals, Inc. - Pipeline Products by Target 28
Actinium Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 29
Actinium Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 30
Actinium Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 31
Actinium Pharmaceuticals, Inc. - Recent Pipeline Updates 32
Actinium Pharmaceuticals, Inc. - Dormant Projects 41
Actinium Pharmaceuticals, Inc. - Discontinued Pipeline Products 42
Discontinued Pipeline Product Profiles 42
Bismab-A 42
Actinium Pharmaceuticals, Inc. - Locations And Subsidiaries 43
Head Office 43
Appendix 44
Methodology 44
Coverage 44
Secondary Research 44
Primary Research 44
Expert Panel Validation 44
Contact Us 44
Disclaimer 45

List of Tables
Actinium Pharmaceuticals, Inc., Key Information 5
Actinium Pharmaceuticals, Inc., Key Facts 5
Actinium Pharmaceuticals, Inc. - Pipeline by Indication, 2016 8
Actinium Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016 10
Actinium Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016 11
Actinium Pharmaceuticals, Inc. - Phase III, 2016 12
Actinium Pharmaceuticals, Inc. - Phase II, 2016 13
Actinium Pharmaceuticals, Inc. - Phase I, 2016 14
Actinium Pharmaceuticals, Inc. - Preclinical, 2016 15
Actinium Pharmaceuticals, Inc. - Pipeline by Target, 2016 28
Actinium Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016 29
Actinium Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016 30
Actinium Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016 31
Actinium Pharmaceuticals, Inc. - Recent Pipeline Updates, 2016 32
Actinium Pharmaceuticals, Inc. - Dormant Developmental Projects,2016 41
Actinium Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2016 42

List of Figures
Actinium Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2016 7
Actinium Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016 10
Actinium Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016 11
Actinium Pharmaceuticals, Inc. - Pipeline by Target, 2016 28
Actinium Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016 29
Actinium Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016 30
Actinium Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016 31